全文获取类型
收费全文 | 6036篇 |
免费 | 433篇 |
国内免费 | 23篇 |
专业分类
耳鼻咽喉 | 50篇 |
儿科学 | 244篇 |
妇产科学 | 157篇 |
基础医学 | 953篇 |
口腔科学 | 55篇 |
临床医学 | 638篇 |
内科学 | 1182篇 |
皮肤病学 | 62篇 |
神经病学 | 691篇 |
特种医学 | 163篇 |
外科学 | 612篇 |
综合类 | 40篇 |
预防医学 | 639篇 |
眼科学 | 54篇 |
药学 | 488篇 |
中国医学 | 27篇 |
肿瘤学 | 437篇 |
出版年
2024年 | 6篇 |
2023年 | 36篇 |
2022年 | 70篇 |
2021年 | 168篇 |
2020年 | 99篇 |
2019年 | 152篇 |
2018年 | 166篇 |
2017年 | 130篇 |
2016年 | 145篇 |
2015年 | 173篇 |
2014年 | 197篇 |
2013年 | 309篇 |
2012年 | 424篇 |
2011年 | 495篇 |
2010年 | 262篇 |
2009年 | 242篇 |
2008年 | 412篇 |
2007年 | 424篇 |
2006年 | 392篇 |
2005年 | 388篇 |
2004年 | 380篇 |
2003年 | 345篇 |
2002年 | 326篇 |
2001年 | 44篇 |
2000年 | 27篇 |
1999年 | 53篇 |
1998年 | 70篇 |
1997年 | 60篇 |
1996年 | 57篇 |
1995年 | 43篇 |
1994年 | 41篇 |
1993年 | 35篇 |
1992年 | 24篇 |
1991年 | 24篇 |
1990年 | 21篇 |
1989年 | 18篇 |
1988年 | 19篇 |
1987年 | 23篇 |
1986年 | 14篇 |
1985年 | 14篇 |
1984年 | 24篇 |
1983年 | 16篇 |
1982年 | 19篇 |
1981年 | 16篇 |
1980年 | 21篇 |
1979年 | 13篇 |
1978年 | 12篇 |
1977年 | 8篇 |
1976年 | 5篇 |
1973年 | 5篇 |
排序方式: 共有6492条查询结果,搜索用时 0 毫秒
81.
82.
83.
84.
Soulié C Malet I Lambert-Niclot S Tubiana R Thévenin M Simon A Murphy R Katlama C Calvez V Marcelin AG 《AIDS (London, England)》2008,22(16):2212-2214
Resistance to CCR5 antagonists can be driven by mutations in gp120. Sequences from 323 anti-CCR5 naive patients were analyzed for the presence of previously described in-vivo or in-vitro resistance mutations to CCR5 antagonists located in the V3 loop of gp120. The V3 loop region was rather polymorphic, and 7.3% of patients showed viruses with combinations of mutations in V3 loop previously described to be involved in maraviroc resistance, a licensed CCR5 antagonist. 相似文献
85.
86.
87.
88.
Limited surgical resection for graft salvage following recovery from complicated exfoliative rejection in pediatric intestinal recipients 下载免费PDF全文
Monique L. Goldschmidt Samuel A. Kocoshis Gregory M. Tiao Maria H. Alonso Jaimie D. Nathan 《Pediatric transplantation》2015,19(7):E170-E176
Complications of ER contribute significantly to morbidity and mortality following intestinal transplantation. The surgical management of three pediatric patients who experienced complications of late ER after composite LSB transplantation is described, highlighting the potential for allograft salvage after limited surgical resection. A retrospective case series was compiled. Data collected included time to ER from transplant, medical management of ER, complications, and surgical management of ER complications. All patients had undergone composite LSB transplantation between one and two yr of age. Time to ER after transplantation was 9.5–26.5 months. ER complications included ileal allograft stricture, intramural hematoma with perforation of jejunal allograft, and massive GI hemorrhage secondary to focal ulceration and pseudopolyp formation. With evidence of mucosal regeneration, all three patients underwent limited segmental allograft resection. Two patients continue to maintain satisfactory allograft function 39–44 months following operation. The third patient retained adequate allograft function until he developed PTLD, subsequently dying from disseminated Adenovirus infection 51 months after resection. Severe disruption of intestinal allograft integrity in ER can lend itself to medically refractory complications. Prompt recognition and surgical correction of complications can play a crucial role in allograft salvage and patient survival after ER. 相似文献
89.
Zampieron A Harrington M Elseviers M Lindley E De Vos JY Visser R 《EDTNA/ERCA journal (English ed.)》2004,30(2):59-61
The Research Board (RB) of EDTNA/ERCA is a multidisciplinary group, established by the participation of renal care centres all around Europe. The RB also works with the association's Special Interest Groups (SIGs) on developing guidelines for implementing safe renal clinical practice. It is composed of six permanent members, with co-opted experts from specific fields. This article describes how the RB works and the projects implemented since 1996. 相似文献
90.
Zampieron A Jayasekera H Elseviers M Lindley E De Vos JY Visser R Harrington M 《EDTNA/ERCA journal (English ed.)》2004,30(2):84-90
Haemodialysis patients are known to be at risk of infection of Hepatitis C Virus (HCV) through nosocomial spread. This paper presents the first part of a study on epidemiology and management of HCV, in a haemodialysis population, conducted by the EDTNA/ERCA Research Board. Data on HCV management and infection control procedures was collected from 136 European centres using an electronic questionnaire. The study identifies a number of possible risk factors for transmission of the virus: failing to disinfect devices between patients, sharing of single-use vials to prepare drugs or infusions for different patients, inadequate sterilisation or cleaning of machines between dialysis sessions, unsatisfactory environmental cleaning and distance less than one metre between chairs. 相似文献